Hong Kong research team opens up new directions for SCAs treatment

Netherlands Innovation Network ChinaLife Sciences & Health Leave a Comment

A research team led by Prof. Chan of the School of Life Sciences at The Chinese University of Hong Kong (CUHK) has just published findings that could enable new therapeutic directions for the treatment of spinocerebellar ataxias (SCAs), a genetic disorder that causes deterioration of the cerebellum. According to the CUHK press release, the team has “unveiled the role played by the ‘nucleolar stress signalling pathway’ in the currently incurable disease, spinocerebellar ataxias (SCAs), opening up new therapeutic directions for SCAs treatment at the RNA level. The work was recently published in one of the most-cited multidisciplinary scientific journals, Proceedings of the National Academy of Sciences U.S.A.”.

Read the full article on the CUHK website.

Leave a Reply

Your email address will not be published. Required fields are marked *